Leukemia & Lymphoma, 1029-2403

Tidskrift

Fler filtreringsmöjligheter
  1. Artikel i vetenskaplig tidskrift
  2. Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML

    Delsing Malmberg, E., Johansson Alm, S., Nicklasson, M., Lazarevic, V., Ståhlman, S., Samuelsson, T., Lenhoff, S., Asp, J., Mats Ehinger, Palmqvist, L., Brune, M. & Fogelstrand, L., 2019, I : Leukemia and Lymphoma. 60, 2, s. 409-417

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations

    Dreyling, M., Aurer, I., Cortelazzo, S., Hermine, O., Hess, G., Mats Jerkeman, Le Gouill, S., Ribrag, V., Trněný, M., Visco, C., Walewski, J., Zaja, F. & Zinzani, P. L., 2018, I : Leukemia and Lymphoma. 59, 8, s. 1814-1828

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study

    Henrik Cederleuf, Hjort Jakobsen, L., Fredrik Ellin, de Nully Brown, P., Stauffer Larsen, T., Bøgsted, M., Relander, T., Mats Jerkeman & El-Galaly, T. C., 2017 dec 2, I : Leukemia and Lymphoma. 58, 12, s. 2815-2823 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker

    Hasni, M. S., Berglund, M., Yakimchuk, K., Guan, J., Linderoth, J., Amini, R-M., Enblad, G. & Okret, S., 2017 feb 1, I : Leukemia & Lymphoma. 58, 2, s. 418-427 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemia

    Yektaei-Karin, E., Zovko, A., Nilsson, A., Näsman-Glaser, B., Kanter, L., Rådmark, O., Wallvik, J., Marja Ekblom, Dolinska, M., Qian, H. & Stenke, L., 2017, I : Leukemia & Lymphoma. 58, 8, s. 1903-1913 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus

    Hess, G., Rule, S., Jurczak, W., Mats Jerkeman, Santucci Silva, R., Rusconi, C., Caballero, D., Joao, C., Witzens-Harig, M., Bence-Bruckler, I., Cho, S-G., Zhou, W., Goldberg, J. D., Trambitas, C., Enny, C., Vermeulen, J., Traina, S., Chiou, C. F., Diels, J. & Dreyling, M., 2017, I : Leukemia and Lymphoma. 58, 12, s. 2824-2832

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma.

    Venera Kuci, Nordström, L., Conrotto, P. & Sara Ek, 2016, I : Leukemia & Lymphoma.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Single nucleotide polymorphism array analysis of clonal evolution in younger adult acute lymphoblastic leukemia

    Dirse, V., Gineikiene, E., Zvirblis, T., Bertasiute, R., Kajsa Paulsson & Griskevicius, L., 2016, I : Leukemia & Lymphoma. 57, 11, s. 2716-2719 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia

    Ivanov Öfverholm, I., Tran, A. N., Linda Olsson, Zachariadis, V., Heyman, M., Rudd, E., Syk Lundberg, E., Nordenskjöld, M., Bertil Johansson, Nordgren, A. & Barbany, G., 2016, I : Leukemia & Lymphoma. 57, 9, s. 2161-2170 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. F-18-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study

    Mylam, K. J., Kostakoglu, L., Hutchings, M., Coleman, M., Lamonica, D., Czuczman, M. S., Diehl, L. F., Nielsen, A. L., Jensen, P., Loft, A., Hendel, H. W., Iyer, V., Leppa, S., Jyrkkio, S., Holte, H., Eriksson, M., Gillstrom, D., Hansen, P. B., Seppanen, M., Hjorthaug, K. & 2 andraBrown, P. D. N. & Pedersen, L. M., 2015, I : Leukemia & Lymphoma. 56, 7, s. 2005-2012

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib

    Ohm, L., Lundqvist, A., Dickman, P., Hoglund, M., Persson, U., Stenke, L., Carlsson, K. S. & Bjorkholm, M., 2015, I : Leukemia & Lymphoma. 56, 5, s. 1385-1391

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Joint occurrence of Merkel cell carcinoma and non-Hodgkin lymphomas in four Nordic countries

    Koljonen, V., Rantanen, M., Sahi, H., Mellemkjaer, L., Hansen, B. T., Chen, T., Kari Hemminki & Pukkala, E., 2015, I : Leukemia & Lymphoma. 56, 12, s. 3315-3319

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas

    Högfeldt, T., Johnsson, P., Grandér, D., Bahnassy, A. A., Anna Porwit, Eid, S., Österborg, A., Zekri, A. R. N., Lundahl, J., Khaled, M. H., Mellstedt, H. & Moshfegh, A., 2014 jan 1, I : Leukemia and Lymphoma. 55, 5, s. 1158-1165

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic

    Mulligan, S. P., Karlsson, K., Stromberg, M., Jonsson, V., Gill, D., Hammerstrom, J., Hertzberg, M., McLennan, R., Uggla, B., Norman, J., Wallvik, J., Sundstrom, G., Johansson, H., Brandberg, Y., Liliemark, J. & Gunnar Juliusson, 2014, I : Leukemia & Lymphoma. 55, 12, s. 2769-2777

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?

    Machaczka, M., Johansson, J-E., Remberger, M., Hallbook, H., Malm, C., Lazarevic, V., Wahlin, A., Omar, H., Gunnar Juliusson, Kimby, E. & Hagglund, H., 2012, I : Leukemia & Lymphoma. 53, 9, s. 1699-1705

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma

    Fjordén, K., Joost, P., Mats Ehinger, Patrik Edén, Mats Jerkeman, Cavallin-Ståhl, E. & Linderoth, J., 2012, I : Leukemia & Lymphoma. 53, 9, s. 1764-1768

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Marked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma Registry.

    Abrahamsson, A., Dahle, N. & Mats Jerkeman, 2011, I : Leukemia & Lymphoma. 52, 10, s. 1929-1935

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study.

    Tove Wästerlid, Jonsson, B., Hagberg, H. & Mats Jerkeman, 2011, I : Leukemia & Lymphoma. 52, 11, s. 2090-2096

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden.

    Lj Lazarevic, V., H X00e4 Gglund, H., Remberger, M., Wahlin, A., Hallb X00f6 X00f6 K, H., Gunnar Juliusson, Kimby, E., Malm, C., Omar, H. & Johansson, J-E., 2011, I : Leukemia & Lymphoma. 52, s. 69-71

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. 'Hairy' cells: where are the roots of this leukemia?

    Gunnar Juliusson, Tadmor, T. & Polliack, A., 2011, I : Leukemia & Lymphoma. 52, s. 2205-2206

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Hairy cell leukemia: epidemiology, pharmacokinetics of cladribine, and long-term follow-up of subcutaneous therapy.

    Gunnar Juliusson & Samuelsson, H., 2011, I : Leukemia & Lymphoma. 52 Suppl 2, s. 46-49

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

    Fjordén, K., Linderoth, J., Nyman, H., Mats Ehinger, Joost, P., Pär-Ola Bendahl, Leppä, S. & Mats Jerkeman, 2010, I : Leukemia & Lymphoma. 51, s. 1643-1648

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Molecular mechanisms of resistance to Rituximab and pharmacologic strategies for its circumvention.

    Stolz, C. & Schuler, M., 2009, I : Leukemia & Lymphoma. 50, s. 873-885

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Fludarabine, cyclophosphamide and rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia

    Lazarevic, V. L., Liljeholm, M., Forsberg, K., Söderberg, S. & Wahlin, A., 2008 jun, I : Leukemia & Lymphoma. 49, 6, s. 1209-11 3 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 Nästa